Sandra Coufal
Vorstandsvorsitzender bei Toragen, Inc.
Profil
Sandra I.
Coufal is the founder of Relypsa, Inc. (founded in 2007) and Sibling Capital LLC (founded in 2012).
She is currently the Chief Executive Officer & Director at Toragen, Inc., and a Director at Safety Spot, Inc., Bioaesthetics Corp., and La Jolla Country Day School.
Her former positions include being an Independent Director at Tricida, Inc. (2013-2023), Director at Scripps Green Hospital (1997-1999), Principal at Ilypsa, Inc., and Head-Internal Medicine Division at Scripps Clinic Medical Group, Inc. (1997-1999).
Dr. Coufal received her undergraduate degree from the University of Notre Dame in 1982 and her doctorate from The University of Texas Southwestern Medical Center.
Aktive Positionen von Sandra Coufal
Unternehmen | Position | Beginn |
---|---|---|
Safety Spot, Inc.
Safety Spot, Inc. Packaged SoftwareTechnology Services Safety Spot, Inc. develops a web-based platform for training, consumables, scheduling, maintenance, and asset management in organizations. It allows users to create organization and accounts for personnel, visitors, and contractors; update organization’s emergency info, sites, assets, systems, and trainings. The company was founded by Diego Diaz and Brandon Iglesias and is headquartered in Los Angeles, CA. | Direktor/Vorstandsmitglied | 01.03.2017 |
Bioaesthetics Corp.
Bioaesthetics Corp. Miscellaneous Commercial ServicesCommercial Services Bioaesthetics Corp. provides biotechnology health care services. The company was founded by Nicholas C. Pashos and is headquartered in New Orleans, LA. | Direktor/Vorstandsmitglied | 01.02.2016 |
Toragen, Inc.
Toragen, Inc. BiotechnologyHealth Technology Toragen, Inc. is a clinical-stage biotechnology company that is focused on developing treatments for HPV-induced cancers, starting with head and neck cancer. Toragen is based in San Diego, CA. The company is targeting the root cause of virally induced cancers. The company was founded by Andrew Sharabi and the CEO is Sandra I. Coufal. | Vorstandsvorsitzender | - |
La Jolla Country Day School | Direktor/Vorstandsmitglied | 01.07.2020 |
Ehemalige bekannte Positionen von Sandra Coufal
Unternehmen | Position | Ende |
---|---|---|
Sibling Capital LLC
Sibling Capital LLC Investment ManagersFinance Sibling Capital LLC (Sibling Capital) is a private equity firm founded in 2012 by Sandra I. Coufal and Brian M. Isern. The firm is headquartered in Santa Fe, California. | Gründer | 01.06.2023 |
TRICIDA, INC. | Direktor/Vorstandsmitglied | 01.06.2023 |
Scripps Clinic Medical Group, Inc. | Corporate Officer/Principal | 01.01.1999 |
Scripps Green Hospital
Scripps Green Hospital Hospital/Nursing ManagementHealth Services Scripps Green Hospital operates as a hospital. The private company is based in La Jolla, CA. | Direktor/Vorstandsmitglied | 01.01.1999 |
Ilypsa, Inc.
Ilypsa, Inc. BiotechnologyHealth Technology Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | - |
Ausbildung von Sandra Coufal
University of Notre Dame | Undergraduate Degree |
The University of Texas Southwestern Medical Center | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
TRICIDA, INC. | Health Technology |
Private Unternehmen | 8 |
---|---|
Sibling Capital LLC
Sibling Capital LLC Investment ManagersFinance Sibling Capital LLC (Sibling Capital) is a private equity firm founded in 2012 by Sandra I. Coufal and Brian M. Isern. The firm is headquartered in Santa Fe, California. | Finance |
Relypsa, Inc.
Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Relypsa, Inc. operates as a bio-pharmaceutical company, which engages in the development and commercialization of late-stage medicines in the iron deficiency, nephrology, and cardio-renal therapeutic areas. It offers Veltassa, a potassium binder approved for the treatment of hyperkalemia. The company was founded by Jerry M. Buysse, Gerrit Klaerner, Michael Burdick, Jay P. Shepard, Detlef F. Albrecht, George Tyson, Sandra I. Coufal and Vic Ciaravino on October 29, 2007 and is headquartered in Redwood City, CA. | Health Technology |
Ilypsa, Inc.
Ilypsa, Inc. BiotechnologyHealth Technology Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA. | Health Technology |
Scripps Clinic Medical Group, Inc. | |
Safety Spot, Inc.
Safety Spot, Inc. Packaged SoftwareTechnology Services Safety Spot, Inc. develops a web-based platform for training, consumables, scheduling, maintenance, and asset management in organizations. It allows users to create organization and accounts for personnel, visitors, and contractors; update organization’s emergency info, sites, assets, systems, and trainings. The company was founded by Diego Diaz and Brandon Iglesias and is headquartered in Los Angeles, CA. | Technology Services |
Bioaesthetics Corp.
Bioaesthetics Corp. Miscellaneous Commercial ServicesCommercial Services Bioaesthetics Corp. provides biotechnology health care services. The company was founded by Nicholas C. Pashos and is headquartered in New Orleans, LA. | Commercial Services |
Scripps Green Hospital
Scripps Green Hospital Hospital/Nursing ManagementHealth Services Scripps Green Hospital operates as a hospital. The private company is based in La Jolla, CA. | Health Services |
Toragen, Inc.
Toragen, Inc. BiotechnologyHealth Technology Toragen, Inc. is a clinical-stage biotechnology company that is focused on developing treatments for HPV-induced cancers, starting with head and neck cancer. Toragen is based in San Diego, CA. The company is targeting the root cause of virally induced cancers. The company was founded by Andrew Sharabi and the CEO is Sandra I. Coufal. | Health Technology |